PIM1 and prostate neoplasm: When overall PIM mRNA expression levels were compared with this larger dataset, the results were fairly similar to our Tampere PCa dataset, although no significant differences were detected between the samples from normal prostates and primary prostate tumors or metastasized CRPC tumors, and no Gleason score‐dependent differences were detected.